Phase 2 trial of ISIS 104838 for the treatment of Rheumatoid Arthritis - Isis Pharmaceuticals, Inc. - Earnings TranscriptMonday, January 05, 2004 03:00
This is a single user license, allowing one specific user access to the product. The transcript will be emailed to you.
order by fax
need a quote
The service from your team is great and very helpful.
We request your telephone number so we can contact you in the event we have difficulty reaching you via email